חזרה לתוצאות החיפוש

Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Severe Hemophilia A

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Feng Xue)

  • Fuyang Hospital, Affiliated to Anhui Medical University, Fuyang, China

    Contact: Study coordinator (Qingyi Wang)

  • Fujian Medical University Union Hospital, Fuzhou, China

    Contact: Study coordinator (Meijuan Huang)

  • Nanfang Hospital of Southern Medical University, Guangzhou, China

    Contact: Study coordinator (Jing Sun)

  • Anhui Provincial Hospital, Hefei, China

    Contact: Study coordinator (Xiaoyu Zhu)

  • Jinan central hospital, Jinan, China

    Contact: Study coordinator (Yun Chen)

  • The Second Affiliated Hospital of Kunming Medical University, Kunming, China

    Contact: Study coordinator (Zeping Zhou)

  • The First Affiliated Hospital of Guangxi Medical University, Nanning, China

    Contact: Study coordinator (Peng Cheng)

  • Affiliated Hospital of Nantong University, Nantong, China

    Contact: Study coordinator (Li Yang)

  • The First Affiliated Hospital of Nanyang Medical College, Nanyang, China

    Contact: Study coordinator (Huibing Dang)

  • Qinghai Provincial People's Hospital, Qinghai, China

    Contact: Study coordinator (Wenqian Li)

  • The Second Hospital of Shanxi Medical University, Taiyuan, China

    Contact: Study coordinator (Zhuanzhen Zheng)

  • North China University of Science and Technology Affiliated Hospital, Tangshan, China

    Contact: Study coordinator (Zhenyu Yan)

  • Wenzhou People's Hospital, Wenzhou, China

    Contact: Study coordinator (Miaoyong Zhu)

  • Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology., Wuhan, China

    Contact: Study coordinator (Huafang Wang)

  • Affiliated Hospital of Jiangnan University, Wuxi, China

    Contact: Study coordinator (Haiying Hua)

  • Xi'an Central Hospital, Xi'an, China

    Contact: Study coordinator (Yanping Song)

  • Henan Cancer Hospital, Zhengzhou, China

    Contact: Study coordinator (Hu Zhou)

  • Zhengzhou People's Hospital, Zhengzhou, China

    Contact: Study coordinator (Shuxia Guo)
מובילי המחקר

  • Renchi Yang, PhD

    Study Chair

    Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College.

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)